We just received data on a new analyst forecast for $RYTM. Joseph Stringer from Needham set a price target of 145.0 for RYTM.
To track analyst ratings and price targets for $RYTM, check out Quiver Quantitative's $RYTM forecast page.
Should you buy $RYTM?
Some analysts are better than others. To view the past performance of Needham, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$RYTM Price Targets
Multiple analysts have issued price targets for $RYTM recently. We have seen 12 analysts offer price targets for $RYTM in the last 6 months, with a median target of $124.5.
Here are some recent targets:
- Joseph Stringer from Needham set a target price of $145.0 on 12/11/2025
- Samantha Semenkow from Citigroup set a target price of $136.0 on 11/25/2025
- Whitney Ijem from Canaccord Genuity set a target price of $114.0 on 11/10/2025
- Corinne Jenkins from Goldman Sachs set a target price of $139.0 on 10/17/2025
- Jeffrey Hung from Morgan Stanley set a target price of $129.0 on 10/16/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $110.0 on 09/29/2025
- Jonathan Wolleben from JMP Securities set a target price of $142.0 on 09/25/2025
$RYTM Insider Trading Activity
$RYTM insiders have traded $RYTM stock on the open market 27 times in the past 6 months. Of those trades, 0 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $RYTM stock by insiders over the last 6 months:
- JOSEPH SHULMAN (Chief Technical Officer) has made 0 purchases and 10 sales selling 59,922 shares for an estimated $6,229,322.
- HUNTER C SMITH (Chief Financial Officer) has made 0 purchases and 5 sales selling 70,208 shares for an estimated $6,094,379.
- PAMELA J. CRAMER (Chief Human Resources Officer) has made 0 purchases and 7 sales selling 43,308 shares for an estimated $3,947,251.
- CHRISTOPHER PAUL GERMAN (Corporate Controller & CAO) has made 0 purchases and 3 sales selling 5,317 shares for an estimated $450,717.
- ALASTAIR GARFIELD (Chief Scientific Officer) has made 0 purchases and 2 sales selling 1,319 shares for an estimated $85,483.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RYTM Hedge Fund Activity
We have seen 157 institutional investors add shares of $RYTM stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 1,407,313 shares (+39.2%) to their portfolio in Q3 2025, for an estimated $142,124,539
- ALLIANCEBERNSTEIN L.P. added 918,212 shares (+1493.8%) to their portfolio in Q3 2025, for an estimated $92,730,229
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 678,760 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,890,844
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 647,317 shares (+284.4%) to their portfolio in Q3 2025, for an estimated $65,372,543
- PRIMECAP MANAGEMENT CO/CA/ removed 615,178 shares (-12.6%) from their portfolio in Q3 2025, for an estimated $62,126,826
- CAPITAL RESEARCH GLOBAL INVESTORS added 598,247 shares (+inf%) to their portfolio in Q3 2025, for an estimated $60,416,964
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 560,464 shares (-34.4%) from their portfolio in Q3 2025, for an estimated $56,601,259
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
